Show simple item record

dc.contributor.authorde Vos, M
dc.contributor.authorLey, SD
dc.contributor.authorWiggins, KB
dc.contributor.authorDerendinger, B
dc.contributor.authorDippenaar, A
dc.contributor.authorGrobbelaar, M
dc.contributor.authorReuter, A
dc.contributor.authorDolby, T
dc.contributor.authorBurns, S
dc.contributor.authorSchito, M
dc.contributor.authorEngelthaler, DM
dc.contributor.authorMetcalfe, J
dc.contributor.authorTheron, G
dc.contributor.authorvan Rie, A
dc.contributor.authorPosey, J
dc.contributor.authorWarren, R
dc.contributor.authorCox, H
dc.date.accessioned2020-06-23T18:39:47Z
dc.date.available2020-06-23T18:39:47Z
dc.date.issued2019-05-30
dc.date.submitted2020-05-29
dc.identifier.pmid31141643
dc.identifier.doi10.1056/NEJMc1815121
dc.identifier.urihttp://hdl.handle.net/10144/619633
dc.descriptionWe regret that this article is behind a paywall.en_US
dc.language.isoenen_US
dc.publisherMassachusetts Medical Societyen_US
dc.titleBedaquiline Microheteroresistance after Cessation of Tuberculosis Treatmenten_US
dc.typeOther
dc.typeOther
dc.identifier.eissn1533-4406
dc.identifier.journalThe New England Journal of Medicineen_US
dc.source.journaltitleThe New England journal of medicine
dc.source.volume380
dc.source.issue22
dc.source.beginpage2178
dc.source.endpage2180
dc.source.countryInternational
dc.source.countryUnited States
dc.source.countryUnited Kingdom
dc.source.countryInternational
dc.source.countryInternational
dc.source.countryUnited States
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record